Sinovac

A signage of Sinovac Biotech Ltd is seen at the 2020 China International Fair for Trade in Services (CIFTIS), following the Covid-19 outbreak, in Beijing, China September 5, 2020. Photo:Reuters
Coronavirus chronicle

Ukraine approves China's Sinovac Covid-19 vaccine

Ukrainian pharmaceutical company Lekhim said last month it had submitted documents to Ukrainian authorities seeking approval for Sinovac

A signage of Sinovac Biotech Ltd is seen at the 2020 China International Fair for Trade in Services (CIFTIS), following the Covid-19 outbreak, in Beijing, China September 5, 2020. Photo:Reuters
Coronavirus chronicle

Hong Kong advisory panel approves China's Sinovac Covid-19 vaccine for emergency use

FILE PHOTO: A worker performs a quality check in the packaging facility of Chinese vaccine maker Sinovac Biotech, developing an experimental coronavirus disease (COVID-19) vaccine, during a government-organized media tour in Beijing, China, September 24, 2020. REUTERS/Thomas Peter/File Photo
Coronavirus chronicle

Sinovac's Ukrainian partner seeks to delay Covid-19 vaccine shipments

FILE PHOTO: An employee holds a vial containing CoronaVac, Sinovac Biotech's vaccine against the coronavirus disease (COVID-19), at Butantan biomedical production center in Sao Paulo, Brazil January 12, 2021. REUTERS/Amanda Perobelli
Coronavirus chronicle

Indonesia approves China's Sinovac vaccine for the elderly

FILE PHOTO: A worker performs a quality check in the packaging facility of Chinese vaccine maker Sinovac Biotech, developing an experimental coronavirus disease (COVID-19) vaccine, during a government-organized media tour in Beijing, China, September 24, 2020. REUTERS/Thomas Peter/File Photo
Coronavirus chronicle

China approves Sinovac Biotech Covid-19 vaccine for general public use

A worker performs a quality check in the packaging facility of Chinese vaccine maker Sinovac Biotech, developing an experimental coronavirus disease (COVID-19) vaccine, during a government-organized media tour in Beijing, China, September 24, 2020. REUTERS/Thomas Peter
Coronavirus chronicle

Sinovac's unit files application for public use of its Covid-19 vaccine to Chinese regulator

A worker performs a quality check in the packaging facility of Chinese vaccine maker Sinovac Biotech, developing an experimental coronavirus disease (COVID-19) vaccine, during a government-organized media tour in Beijing, China, September 24, 2020. REUTERS/Thomas Peter
Coronavirus chronicle

Seven Chinese-made Covid-19 vaccines enter phase-3 clinical trials: Official

A booth displaying a coronavirus vaccine candidate from China National Biotec Group (CNBG), a unit of state-owned pharmaceutical giant China National Pharmaceutical Group (Sinopharm), is seen at the 2020 China International Fair for Trade in Services (CIFTIS), following the Covid-19 outbreak, in Beijing, China September 4, 2020. REUTERS/Tingshu Wang
Coronavirus chronicle

Pakistan approves Chinese Sinopharm Covid-19 vaccine for emergency use

Health care workers receive a dose of the Sinovac's coronavirus disease (COVID-19) vaccine, after Brazil health regulator Anvisa approved its emergency use at Hospital das Clinicas in Sao Paulo, Brazil January 17, 2021. REUTERS/Amanda Perobelli
Coronavirus chronicle

Brazil clears emergency use of Sinovac, AstraZeneca vaccines, shots begin

Sinovac Covid-19 vaccine. Photo/TBS
Coronavirus chronicle

Brazil health regulator says application for Sinovac vaccine lacks information

Representational image. Photo: Collected
Coronavirus chronicle

Hong Kong to get Sinovac, Pfizer/BioNTech vaccines in first quarter

A man works in the packaging facility of Chinese vaccine maker Sinovac Biotech, developing an experimental coronavirus disease (Covid-19) vaccine, during a government-organized media tour in Beijing, China, 24 September, 2020/Reuters
Coronavirus chronicle

Sinovac's Covid-19 vaccine induces quick immune response

Shouldn’t this be available in America? Photographer: Nicolas Bock/Bloomberg
Coronavirus chronicle

Brazil suspends Sinovac Covid-19 vaccine trial due to adverse event